HIGHLIGHTS
- who: Ya-Jen Chiu and collaborators from the Department of Life Science, National Taiwan Normal University, Taipei, Taiwan have published the research: AGING, in the Journal: (JOURNAL)
- what: The authors explored if LM-031 analogs LMDS-1 to -4 may act as TRKB agonists to protect SH-SY5Y cells against Au03b2 toxicity. The authors identified novel potential TRKB agonists with good bioavailability .
- how: These results indicated that the LM-031 and analogs not only hindered the aggregation of amyloid but also attenuated oxidative stress caused by Au03b2 overexpression. Consistent with these previous reports . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.